#USA #LabConnect #Johnson City #Global Services #Bill Finger

LabConnect Announces Bill Finger as Senior Vice President

LabConnect, a leading provider of central laboratory services, has made a significant addition to its executive team by appointing Bill Finger as the Senior Vice President of Global Strategic Services, effective September 10, 2025. With more than 25 years of experience in clinical diagnostics and research, Bill's extensive knowledge of the global laboratory and pharmaceutical sectors positions him as a valuable asset for the company.

Bill Finger’s Experience and Expertise

Bill Finger's career has been marked by a commitment to innovation and operational excellence. Prior to his new role at LabConnect, he served as Vice President and General Manager of Pharma Services at Quest Diagnostics, where he was instrumental in driving growth and improving service delivery. His previous roles include serving as Chief Operating Officer for Interpace Pharma Solutions and Executive Vice President of Precision Medicine and Pharma for Cancer Genetics. Throughout his career, he has consistently showcased his ability to develop effective strategies that enhance company performance while maintaining a strong focus on operational excellence.

In his new position at LabConnect, Bill will lead teams responsible for scientific services, consulting, data management, and Functional Service Provider (FSP) operations. His leadership is expected to bolster LabConnect's capabilities in meeting customer needs and providing innovative solutions.

A Vision for the Future

In a statement, Wes Wheeler, the CEO of LabConnect, expressed excitement about Bill's appointment, stating, "Bill's leadership skills in diagnostics and clinical research are a tremendous asset for LabConnect. His experience will ensure that we continue to anticipate our customers' needs, provide innovative solutions, and enhance our commitment to operational excellence for clients worldwide."

As the demand for innovative solutions in the field of clinical research continues to grow, LabConnect aims to leverage Bill's expertise to strengthen its service offerings and maintain competitive advantages in global markets. The company is dedicated to supporting complex studies, including immuno-oncology, cell and gene therapies, and rare diseases.

About LabConnect

LabConnect is a premier provider of central laboratory services, FSP, scientific consulting, and data integration and transformation services tailored for analytically and logistically complex studies. The company's unique combination of cutting-edge technology, top-tier laboratories, easy access to key and emerging markets, and comprehensive expertise in specialty testing make it a trusted partner for pharmaceutical companies focusing on drug development.

For more information about LabConnect and its wide range of services, visit LabConnect.com or follow them on LinkedIn. This strategic advance in leadership positions LabConnect for further growth as it continues to meet the evolving needs of the industry and its stakeholders.